AMERICAN JOURNAL OF NEURORADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

选刊时需结合分区进行吗？

137 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2021-12-28 rayms

期刊分类很多，如何选择合适的期刊？

143 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2019-09-23 zxt30

我的都with editor 两个月了，是什么情况，可有大侠指导？

276 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-02-06 Atropine1470

这个杂志需要版面费么？

234 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2021-02-24 古天乐

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：胶质瘤MRI影像
经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。

187 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-08-08 146academ18暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted

208 0

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-03-23 146academ18暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
经验分享：1月16投稿 3月23收到“revise and resubmit”

220 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-04-15 146academ18暂无昵称

是的就是在审稿的意思环宇姐姐 2020-03-26 发表::
您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表:
您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定

环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定

157 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-03-26 148910f4m13暂无昵称

您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表::
接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表:
1月16投稿 3月23收到“revise and resubmit”

187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit”

148 0

[GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806897, encodeId=f75e80689e3c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1.19 submit 3.23 revise and resubmit 4.19 resubmit 7.18 minor revision 8. 6 submit 8.8 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Sat Aug 08 09:41:57 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587178, encodeId=093e58e178fa, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月16投稿 3月23收到“revise and resubmit” , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588988, encodeId=d5335889888c, content=是的就是在审稿的意思环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定环宇姐姐 2020-03-26 00:00:00 发表: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, beContent=环宇姐姐 2020-03-26 发表:: 您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587484, encodeId=3b0958e484cd, content=您好想请问一下显示under review就是在审的意思吗？因为一个作者没有收到disclosure的邮件，给编辑写信也没有回复，但是一天后在ajnr账户里显示着under review 有点不确定187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” 187****8818暂无昵称 2020-03-23 00:00:00 发表: 1月16投稿 3月23收到“revise and resubmit” , beContent=187****8818暂无昵称 2020-03-23 发表:: 接收率：约50% 审稿时间：约2个月 1月16投稿 3月23收到“revise and resubmit” , objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de2d5313345, createdName=148910f4m13暂无昵称, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582480, encodeId=02d758248057, content=临床文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]

2020-01-01 145b138dm45暂无昵称

临床文章收吗？

146 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务